ZOLAT

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOLAT contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3230	Suspension	Zolat Suspension SUSP 100 mg/5 mL		28/09/2020
A11-0721	Tablet	ZOLAT CHEWABLE TABLET TAB 400 mg x100,1x1	ZOLAT CHEWABLE TABLET ALBENDAZOLE 400MG ALBEDAZOLE 400MG A11-0721 Drugs ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS Nigerian Products x100,1x1 POM 1 24/07/2023 EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 chinelo@emzorpharma.com EMZOR PHARMACEUTICAL INDUSTRIES LTD, No 13,Richfield Avenue,Ajao Estate,Lagos, Nigeria	30/11/2023
A11-0722	Tablet	ZOLAT 400MG CAPLET TAB 400 mg X100,1X1	ZOLAT 400MG CAPLET ALBENDAZOLE 400MG ALBENDAZOLE 400MG A11-0722 Drugs Nigerian Products X100,1X1 POM 1 26/07/2023 EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 chinelo@emzorpharma.com EMZOR PHARMACEUTICAL INDUSTRIES LTD, No 13,Richfield Avenue,Ajao Estate,Lagos, Nigeria	28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-3230, 04-3309, A11-0721, A11-0722